前收市價 | 26.32 |
開市 | 26.25 |
買盤 | 26.28 x 3200 |
賣出價 | 26.19 x 1300 |
今日波幅 | 26.04 - 26.34 |
52 週波幅 | 25.23 - 40.37 |
成交量 | |
平均成交量 | 42,576,651 |
市值 | 148.755B |
Beta 值 (5 年,每月) | 0.57 |
市盈率 (最近 12 個月) | 71.00 |
每股盈利 (最近 12 個月) | 0.37 |
業績公佈日 | 2024年5月01日 |
遠期股息及收益率 | 1.68 (6.38%) |
除息日 | 2024年1月25日 |
1 年預測目標價 | 31.10 |
Pfizer stock remains under pressure despite becoming one of the biggest names of the pandemic. Is PFE stock a sell?
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.
Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.